Skip to main content Skip to section navigation Skip to footer
Investors Back To Corporate Site >

Journey Medical Corporation

  • Investors
  • Overview
  • Company
    • About Us
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock
    • Quote
    • Historical Data
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Analyst Coverage
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy

NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg

Learn More

NOW APPROVED

Journey Medical Corporation Announces the U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg for Treatment of Papulopustular Rosacea.

Learn More

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
Nov 12, 2024

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Nov 4, 2024

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Oct 25, 2024

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Oct 3, 2024

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 9, 2024

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Sep 4, 2024

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 12, 2024

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Aug 6, 2024

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

Jul 11, 2024

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

May 15, 2024

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2025 Journey Medical Corporation. All Rights Reserved.
Linkedin Logo Privacy Policy Terms of Use Sitemap

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.